These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2597429)

  • 1. Addressing unanswered questions about population cholesterol screenings: the Model Systems for Blood Cholesterol Screening Program.
    Havas S; Greenland P; Wones R; Schucker B
    Am J Prev Med; 1989; 5(6):337-46. PubMed ID: 2597429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for high blood cholesterol.
    Schucker B; Bradford RH
    Clin Lab Med; 1989 Mar; 9(1):29-36. PubMed ID: 2647374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State-specific cholesterol screening trends--United States, 1991-1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Aug; 49(33):750-5. PubMed ID: 11758643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional cholesterol screening: problems and potentials.
    Lansing AM; Barbie RN; Shaheen KA
    J Ky Med Assoc; 1990 Apr; 88(4):170-4. PubMed ID: 2110237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community screening outcomes for diabetes, hypertension, and cholesterol: Nashville REACH 2010 project.
    Patel K; Larson C; Hargreaves M; Schlundt D; Wang H; Jones C; Beard K
    J Ambul Care Manage; 2010; 33(2):155-62. PubMed ID: 20228639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in cholesterol knowledge and screening and hypercholesterolemia awareness and treatment, 1980-1992. The Minnesota Heart Survey.
    Pieper RM; Arnett DK; McGovern PG; Shahar E; Blackburn H; Luepker RV
    Arch Intern Med; 1997 Nov; 157(20):2326-32. PubMed ID: 9361573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reflotron performance in a community screening program: results of the Massachusetts Model Systems for Blood Cholesterol Screening Project.
    Havas S; Bishop R; Koumjian L; Reisman J; Wozenski S
    Am J Prev Med; 1991; 7(6):397-405. PubMed ID: 1790049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in cholesterol screening and awareness of high blood cholesterol--United States, 1991-2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(35):865-70. PubMed ID: 16151370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attendance patterns and characteristics of participants in public cholesterol screening.
    Greenland P; Hildreth NG; Maiman LA
    Am J Prev Med; 1992; 8(3):159-64. PubMed ID: 1633003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Population screening on a population level in Leipzig within the scope of the Bavarian cholesterol project].
    Richter V; Rassoul F; Reuter W; Otto J; Richter WO; Schwandt P; Rotzsch W
    Z Gesamte Inn Med; 1992 Aug; 47(8):359-61. PubMed ID: 1413928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparities in cholesterol screening: falling short of a national health objective.
    Brown DW; Giles WH; Greenlund KJ; Croft JB
    Prev Med; 2001 Dec; 33(6):517-22. PubMed ID: 11716645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for raised cholesterol in a small suburban town.
    Almond D; Graham M
    Practitioner; 1989 Apr; 233(1467):568-70. PubMed ID: 2619833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physician reaction to a local community cholesterol screening program.
    Buchta WG; Wissell RA; Bagley RC; Greaves WW
    Arch Intern Med; 1989 Nov; 149(11):2479-81. PubMed ID: 2818108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Labeling of participants in high blood pressure screening programs. Implications for blood cholesterol screenings.
    Lefebvre RC; Hursey KG; Carleton RA
    Arch Intern Med; 1988 Sep; 148(9):1993-7. PubMed ID: 3046540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors related to cholesterol screening and cholesterol level awareness--United States, 1989.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1990 Sep; 39(37):633-7. PubMed ID: 2118589
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessing risk using different cholesterol-screening methods.
    Bowden RG; Kingery PM; Rust DM
    Public Health; 2004 Apr; 118(3):225-9. PubMed ID: 15003412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision of a dry-chemistry method of lipid screening.
    Bowden RG; Kingery PM; Long L
    Public Health; 2006 Jun; 120(6):572-6. PubMed ID: 16730036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. State-specific trends in high blood cholesterol awareness among persons screened--United States, 1991-1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Sep; 50(35):754-8. PubMed ID: 11787583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High serum total cholesterol--an indicator for monitoring cholesterol lowering efforts: U.S. adults, 2005-2006.
    Schober SE; Carroll MD; Lacher DA; Hirsch R;
    NCHS Data Brief; 2007 Dec; (2):1-8. PubMed ID: 19389314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of different blood lipid evaluation and treatment guidelines on the proportion of Canadians identified and treated for elevated blood cholesterol. Canadian Heart Health Surveys Research Group.
    MacLean DR; Petrasovits A; Connelly PW; Little JA; O'Connor B
    Can J Cardiol; 1999 Apr; 15(4):445-51. PubMed ID: 10322254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.